Trifluoroacetic acid → 6-AMINO-N-(4-{4-[4-(3-CHLORO-PHENYLAMINO)-5-OXO-6,7-DIHYDRO-5H-5lambda4-THIENO[3,2-D]-PYRIMIDIN-2-YL]-PIPERAZIN-1-YL}-PHENYL)-NICOTINAMIDE TRIFLUOROACETATE

HRID 1911065

Reaktionsgleichung

Reaktionsgleichung von HRID 1911065
[F:1][C:2]([F:7])([F:6])[C:3]([OH:5])=[O:4].[NH2:8][C:9]1[CH:14]=[CH:13][C:12]([N:15]2[CH2:20][CH2:19][N:18]([C:21]3[N:22]=[C:23]([NH:31][C:32]4[CH:37]=[CH:36][CH:35]=[C:34]([Cl:38])[CH:33]=4)[C:24]4[S:29](=[O:30])[CH2:28][CH2:27][C:25]=4[N:26]=3)[CH2:17][CH2:16]2)=[CH:11][CH:10]=1.CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.[NH2:63][C:64]1[CH:72]=[CH:71][C:67]([C:68](O)=[O:69])=[CH:66][N:65]=1.FC(F)(F)C(O)=O>CS(C)=O.C(N(C(C)C)CC)(C)C.O>[F:1][C:2]([F:7])([F:6])[C:3]([OH:5])=[O:4].[NH2:63][C:64]1[CH:72]=[CH:71][C:67]([C:68]([NH:8][C:9]2[CH:14]=[CH:13][C:12]([N:15]3[CH2:20][CH2:19][N:18]([C:21]4[N:22]=[C:23]([NH:31][C:32]5[CH:37]=[CH:36][CH:35]=[C:34]([Cl:38])[CH:33]=5)[C:24]5[S:29](=[O:30])[CH2:28][CH2:27][C:25]=5[N:26]=4)[CH2:17][CH2:16]3)=[CH:11][CH:10]=2)=[O:69])=[CH:66][N:65]=1

Komponenten

8

Versuchsvorschrift

200 mg of {2-[4-(4-amino-phenyl)-piperazin-1-yl]-5-oxo-6,7-dihydro-5H-5λ4-thieno[3,2-d]pyrimidin-4-yl}-(3-chloro-phenyl)-amine trifluoroacetate are placed in 2.50 ml dimethylsulphoxide and combined with 100 μl diisopropylethylamine and 150 mg O-(7-azabenzotriazol-1-yl-)-N,N,N′,N′-tetramethyluronium-hexafluorophosphate (HATU). The mixture is stirred for 0.25 hours at ambient temperature, then 50 mg 6-aminonicotinic acid in 100 μl diisopropylethylamine are added. The reaction mixture is stirred for 16 hours at ambient temperature, then acidified with trifluoroacetic acid and 2 ml of water are added. The resulting salt is purified by preparative HPLC (method A). 140 mg of the product are obtained as the trifluoroacetate. Analytical HPLC (method B): RT=2.74 min.

Aufarbeitung

  1. stirringThe reaction mixture is stirred for 16 hours at ambient temperature
  2. additionare added
  3. customThe resulting salt is purified by preparative HPLC (method A)

Quellen und Nachweise

ORD-Eintrag
ord-5b1d73a04b654ab993d7efdcb7cbb763
Quelldatensatz
uspto-grants-2013_12
Patentnummer
US08604039B2

Verknüpfte Notizen

Wird geladen…